AFR Rich List 2024: Behind Ian Malouf's $50m bet on umbilical cords
The Dial-A-Dump founder has shrugged off doubts about stem cell therapy and is investing heavily to get the treatments more widely approved.
Source: afr.com
Stay updated with breaking news from Arugula Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Dial-A-Dump founder has shrugged off doubts about stem cell therapy and is investing heavily to get the treatments more widely approved.